Characterization of CD8+T-Cell Responses in the Peripheral Blood and Skin Injection Sites of Melanoma Patients Treated with mRNA Electroporated Autologous Dendritic Cells (TriMixDC-MEL)
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Characterization of CD8+T-Cell Responses in the Peripheral Blood and Skin Injection Sites of Melanoma Patients Treated with mRNA Electroporated Autologous Dendritic Cells (TriMixDC-MEL)
Authors
Keywords
-
Journal
Biomed Research International
Volume 2013, Issue -, Pages 1-8
Publisher
Hindawi Limited
Online
2013-01-04
DOI
10.1155/2013/976383
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preclinical Evaluation of TriMix and Antigen mRNA-Based Antitumor Therapy
- (2012) S. Van Lint et al. CANCER RESEARCH
- Epitope and HLA-type independent monitoring of antigen-specific T-cells after treatment with dendritic cells presenting full-length tumor antigens
- (2012) An M.T. Van Nuffel et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Dendritic Cells Loaded With mRNA Encoding Full-length Tumor Antigens Prime CD4+ and CD8+ T Cells in Melanoma Patients
- (2012) An MT Van Nuffel et al. MOLECULAR THERAPY
- Parallel detection of antigen-specific T cell responses by combinatorial encoding of MHC multimers
- (2012) Rikke Sick Andersen et al. Nature Protocols
- Intravenous and intradermal TriMix-dendritic cell therapy results in a broad T-cell response and durable tumor response in a chemorefractory stage IV-M1c melanoma patient
- (2011) An M. T. Van Nuffel et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Vaccination of patients with cutaneous melanoma with telomerase-specific peptides
- (2011) Robert E. Hunger et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopes
- (2011) Else M. Inderberg Suso et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- T-Cell Immune Function in Tumor, Skin, and Peripheral Blood of Advanced Stage Melanoma Patients: Implications for Immunotherapy
- (2011) E. P. M. Tjin et al. CLINICAL CANCER RESEARCH
- Therapeutic Vaccination With an Autologous mRNA Electroporated Dendritic Cell Vaccine in Patients With Advanced Melanoma
- (2011) Sofie Wilgenhof et al. JOURNAL OF IMMUNOTHERAPY
- MHC-based detection of antigen-specific CD8+ T cell responses
- (2010) Sine Reker Hadrup et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used
- (2010) W. Joost Lesterhuis et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Simultaneous Detection of Circulating Autoreactive CD8+ T-Cells Specific for Different Islet Cell-Associated Epitopes Using Combinatorial MHC Multimers
- (2010) J. H. Velthuis et al. DIABETES
- CD8 T Cells Activated in Distinct Lymphoid Organs Differentially Express Adhesion Proteins and Coexpress Multiple Chemokine Receptors
- (2010) A. R. Ferguson et al. JOURNAL OF IMMUNOLOGY
- Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination
- (2010) V. F. Van Tendeloo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Single-Step Antigen Loading and Activation of Dendritic Cells by mRNA Electroporation for the Purpose of Therapeutic Vaccination in Melanoma Patients
- (2009) A. Bonehill et al. CLINICAL CANCER RESEARCH
- Strategies and challenges in eliciting immunity to melanoma
- (2008) Andrew R. Ferguson et al. IMMUNOLOGICAL REVIEWS
- Enhancing the T-cell Stimulatory Capacity of Human Dendritic Cells by Co-electroporation With CD40L, CD70 and Constitutively Active TLR4 Encoding mRNA
- (2008) Aude Bonehill et al. MOLECULAR THERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More